CLINICAL TRIALS PROFILE FOR APRACLONIDINE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for APRACLONIDINE HYDROCHLORIDE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00567411 ↗ | Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty | Unknown status | Walter Reed Army Medical Center | N/A | 2006-08-01 | The purpose of the study is to compare the safety and efficacy of two drops used to lower eye pressure when given prior to a glaucoma laser procedure. |
NCT05045248 ↗ | Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis | Completed | American University of Beirut Medical Center | Phase 2 | 2020-06-01 | This study is aimed at assessing the efficacy of Apraclonidine eye drops in the treatment of ptosis secondary to myasthenia gravis. |
NCT05167760 ↗ | Efficacy of Topical Apraclonidine for the Treatment of Ocular Synkinesis | Not yet recruiting | University of Alabama at Birmingham | Phase 4 | 2022-02-01 | The purpose of this study is to determine efficacy of apraclonidine for patients with ocular synkinesis, who are seen in the UAB Facial Nerve Clinic. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for APRACLONIDINE HYDROCHLORIDE
Condition Name
Clinical Trial Locations for APRACLONIDINE HYDROCHLORIDE
Trials by Country
Clinical Trial Progress for APRACLONIDINE HYDROCHLORIDE
Clinical Trial Phase
Clinical Trial Sponsors for APRACLONIDINE HYDROCHLORIDE
Sponsor Name